Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics (DMAC) Amortizatization of Intangibles (2020 - 2026)

DiaMedica Therapeutics filings provide 7 years of Amortizatization of Intangibles readings, the most recent being $190000.0 for Q1 2026.

  • Quarterly Amortizatization of Intangibles fell 27.2% to $190000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $871000.0 through Mar 2026, down 31.69% year-over-year, with the annual reading at $942000.0 for FY2025, 29.86% down from the prior year.
  • Amortizatization of Intangibles hit $190000.0 in Q1 2026 for DiaMedica Therapeutics, down from $252000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $424000.0 in Q3 2023 and bottomed at -$120000.0 in Q1 2022.
  • Average Amortizatization of Intangibles over 5 years is $218176.5, with a median of $249000.0 recorded in 2025.
  • The largest annual shift saw Amortizatization of Intangibles crashed 361.54% in 2022 before it skyrocketed 909.52% in 2023.
  • DiaMedica Therapeutics' Amortizatization of Intangibles stood at $129000.0 in 2022, then skyrocketed by 184.5% to $367000.0 in 2023, then fell by 10.08% to $330000.0 in 2024, then fell by 23.64% to $252000.0 in 2025, then dropped by 24.6% to $190000.0 in 2026.
  • Per Business Quant, the three most recent readings for DMAC's Amortizatization of Intangibles are $190000.0 (Q1 2026), $252000.0 (Q4 2025), and $249000.0 (Q3 2025).